◆ Market Terminal AILook up a stock

Kestra Medical Technologies, Ltd. (KMTS)

Healthcare · Medical - Instruments & Supplies · Small-cap · updated October 16, 2026

NOT A BUY TODAY
What this means. Kestra Medical Technologies, Ltd. is a weaker business by our measures, its shares look expensive compared with other stocks, and its share price trend is middling.
Value35
Quality35
Price trend65
Overall41
2264 of 2764rank among the US stocks we score (our core model buys the top 15)
18%of US stocks we score rank below it

Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.

The business in numbers

Fiscal year to April 2026, from the company's annual filing with the SEC.

Salesyearly sales$95.1M
Sales growthchange from the year before+59.0%
Gross marginshare of sales left after the direct cost of what it sells51.4%
Operating marginshare of sales left after running the business-141.6%
Net marginshare of sales kept as profit-138.4%
Free-cash-flow marginspare cash generated per $100 of sales-122.6%
Return on invested capitalprofit made on each $100 put into the business-32.2%
Return on equityprofit vs. shareholders' accounting value-45.7%
Debt / equitydebt vs. shareholders' accounting value0.15
Interest coverhow many times profit covers interest payments-17.9x
Change in share countnegative = the company is buying back its shares+120.4%

Insider trades, last 90 days

5 insiders sold $2.6M on the open market.

Webster Brian DanielSee Remarks · DirectorSoldAug 313,017 shat $23.92 · $311K
Umberger Traci SSee Remarks · DirectorSoldAug 37,590 shat $23.86 · $181K
Mahboob VaseemChief Financial OfficerSoldAug 35,391 shat $23.80 · $128K

From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.

Higher-scoring in the same industry

Interactive lookupGet the Ledger every Monday

Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy